Recent Updates
Recently added Catalysts
EW Negative Sentiment Score: 25/100

Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law Firm

Key Takeaway: The Portnoy Law Firm has initiated an investigation into Edwards Lifesciences Corporation regarding possible securities fraud, encouraging investors to reach out for legal recourse. This follows a troubling financial performance report for Q2 2024, where the company reduced its revenue guidance for the Transcatheter Aortic Valve Replacement (TAVR) platform. The firm noted that the growth of structural heart therapies has strained hospital resources, potentially impacting TAVR utilization. After these disclosures, Edwards' stock price experienced a drastic decline of approximately 31.34% in one day.

Market Sentiment Analysis

CONCERNS & RISKS

  • Edwards Lifesciences faces an investigation into potential securities fraud.
  • The company reported lower-than-expected financial results for Q2 2024.
  • Edwards cut its full-year revenue guidance for the TAVR platform.
  • The stock price saw a significant drop of approximately 31.34% within a day.

Full Press Release Details

Investors can contact the law firm at no cost to learn more about recovering their losses ​
LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE:EW) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Edwards investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On July 24, 2024, Edwards reported financial results for the second quarter of fiscal 2024 that fell below expectations and, notably, cut its full-year 2024 revenue guidance for its Transcatheter Aortic Valve Replacement (“TAVR”) platform. The Company attributed the TAVR slowdown to the “continued growth and expansion of structural heart therapies … [which] put pressure on hospital workflows.” Investors understood this to mean that the growth of new procedures—including Edwards’ own Transcatheter Mitral and Tricuspid Therapies (“TMTT”)—strained hospital structural heart teams, leading to underutilization of TAVR despite the Company’s repeated assertion of a significantly undertreated patient population. Edwards also announced three acquisitions during the quarter to bolster treatments alternative to TAVR, further suggesting that the Company was aware of the TAVR platform’s decelerating growth.
Following these disclosures, Edwards’ stock price fell sharply, declining from $86.95 per share on July 24, 2024, to $59.70 per share on July 25, 2024—a drop of approximately 31.34% in a single trading day.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bars
Attorney Advertising

Tags

Frequently Asked Questions

How can investors contact the Portnoy Law Firm?

Investors can reach attorney Lesley Portnoy at 310-692-8883 or via email at info@portnoylaw.com.

What triggered the investigation into Edwards Lifesciences?

The investigation was initiated after Edwards reported disappointing Q2 2024 results and lowered its revenue guidance for TAVR.

What happened to Edwards' stock price recently?

Edwards' stock price dropped approximately 31.34%, from $86.95 to $59.70 between July 24 and July 25, 2024.

Is there a cost to contact the Portnoy Law Firm?

No, contacting the Portnoy Law Firm for a case evaluation is free of charge.

What can investors do to recover losses?

Investors can discuss their legal rights and options with the Portnoy Law Firm to pursue claims.

Last updated: Aug 14, 2025